Global Gout Therapeutics Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Report Business Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Gout Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 NSAIDs
  • 1.2.3 Corticosteroids
  • 1.2.4 Colchicine
  • 1.2.5 Urate-Lowering Agents
• 1.3 Market by Application
  • 1.3.1 Global Gout Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Acute Gout
  • 1.3.3 Chronic Gout
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Gout Therapeutics Market Perspective (2017-2028)
• 2.2 Gout Therapeutics Growth Trends by Region
  • 2.2.1 Gout Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 Gout Therapeutics Historic Market Size by Region (2017-2022)
  • 2.2.3 Gout Therapeutics Forecasted Market Size by Region (2023-2028)
• 2.3 Gout Therapeutics Market Dynamics
  • 2.3.1 Gout Therapeutics Industry Trends
  • 2.3.2 Gout Therapeutics Market Drivers
  • 2.3.3 Gout Therapeutics Market Challenges
  • 2.3.4 Gout Therapeutics Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Gout Therapeutics Players by Revenue
  • 3.1.1 Global Top Gout Therapeutics Players by Revenue (2017-2022)
  • 3.1.2 Global Gout Therapeutics Revenue Market Share by Players (2017-2022)
• 3.2 Global Gout Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Players Covered: Ranking by Gout Therapeutics Revenue
• 3.4 Global Gout Therapeutics Market Concentration Ratio
  • 3.4.1 Global Gout Therapeutics Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Gout Therapeutics Revenue in 2021
• 3.5 Gout Therapeutics Key Players Head office and Area Served
• 3.6 Key Players Gout Therapeutics Product Solution and Service
• 3.7 Date of Enter into Gout Therapeutics Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Gout Therapeutics Breakdown Data by Type

• 4.1 Global Gout Therapeutics Historic Market Size by Type (2017-2022)
• 4.2 Global Gout Therapeutics Forecasted Market Size by Type (2023-2028)

5 Gout Therapeutics Breakdown Data by Application

• 5.1 Global Gout Therapeutics Historic Market Size by Application (2017-2022)
• 5.2 Global Gout Therapeutics Forecasted Market Size by Application (2023-2028)

6 North America

• 6.1 North America Gout Therapeutics Market Size (2017-2028)
• 6.2 North America Gout Therapeutics Market Size by Type
  • 6.2.1 North America Gout Therapeutics Market Size by Type (2017-2022)
  • 6.2.2 North America Gout Therapeutics Market Size by Type (2023-2028)
  • 6.2.3 North America Gout Therapeutics Market Share by Type (2017-2028)
• 6.3 North America Gout Therapeutics Market Size by Application
  • 6.3.1 North America Gout Therapeutics Market Size by Application (2017-2022)
  • 6.3.2 North America Gout Therapeutics Market Size by Application (2023-2028)
  • 6.3.3 North America Gout Therapeutics Market Share by Application (2017-2028)
• 6.4 North America Gout Therapeutics Market Size by Country
  • 6.4.1 North America Gout Therapeutics Market Size by Country (2017-2022)
  • 6.4.2 North America Gout Therapeutics Market Size by Country (2023-2028)
  • 6.4.3 U.S.
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Gout Therapeutics Market Size (2017-2028)
• 7.2 Europe Gout Therapeutics Market Size by Type
  • 7.2.1 Europe Gout Therapeutics Market Size by Type (2017-2022)
  • 7.2.2 Europe Gout Therapeutics Market Size by Type (2023-2028)
  • 7.2.3 Europe Gout Therapeutics Market Share by Type (2017-2028)
• 7.3 Europe Gout Therapeutics Market Size by Application
  • 7.3.1 Europe Gout Therapeutics Market Size by Application (2017-2022)
  • 7.3.2 Europe Gout Therapeutics Market Size by Application (2023-2028)
  • 7.3.3 Europe Gout Therapeutics Market Share by Application (2017-2028)
• 7.4 Europe Gout Therapeutics Market Size by Country
  • 7.4.1 Europe Gout Therapeutics Market Size by Country (2017-2022)
  • 7.4.2 Europe Gout Therapeutics Market Size by Country (2023-2028)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 Asia-Pacific

• 8.1 Asia-Pacific Gout Therapeutics Market Size (2017-2028)
• 8.2 Asia-Pacific Gout Therapeutics Market Size by Type
  • 8.2.1 Asia-Pacific Gout Therapeutics Market Size by Type (2017-2022)
  • 8.2.2 Asia-Pacific Gout Therapeutics Market Size by Type (2023-2028)
  • 8.2.3 Asia-Pacific Gout Therapeutics Market Share by Type (2017-2028)
• 8.3 Asia-Pacific Gout Therapeutics Market Size by Application
  • 8.3.1 Asia-Pacific Gout Therapeutics Market Size by Application (2017-2022)
  • 8.3.2 Asia-Pacific Gout Therapeutics Market Size by Application (2023-2028)
  • 8.3.3 Asia-Pacific Gout Therapeutics Market Share by Application (2017-2028)
• 8.4 Asia-Pacific Gout Therapeutics Market Size by Region
  • 8.4.1 Asia-Pacific Gout Therapeutics Market Size by Region (2017-2022)
  • 8.4.2 Asia-Pacific Gout Therapeutics Market Size by Region (2023-2028)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Gout Therapeutics Market Size (2017-2028)
• 9.2 Latin America Gout Therapeutics Market Size by Type
  • 9.2.1 Latin America Gout Therapeutics Market Size by Type (2017-2022)
  • 9.2.2 Latin America Gout Therapeutics Market Size by Type (2023-2028)
  • 9.2.3 Latin America Gout Therapeutics Market Share by Type (2017-2028)
• 9.3 Latin America Gout Therapeutics Market Size by Application
  • 9.3.1 Latin America Gout Therapeutics Market Size by Application (2017-2022)
  • 9.3.2 Latin America Gout Therapeutics Market Size by Application (2023-2028)
  • 9.3.3 Latin America Gout Therapeutics Market Share by Application (2017-2028)
• 9.4 Latin America Gout Therapeutics Market Size by Country
  • 9.4.1 Latin America Gout Therapeutics Market Size by Country (2017-2022)
  • 9.4.2 Latin America Gout Therapeutics Market Size by Country (2023-2028)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Gout Therapeutics Market Size (2017-2028)
• 10.2 Middle East & Africa Gout Therapeutics Market Size by Type
  • 10.2.1 Middle East & Africa Gout Therapeutics Market Size by Type (2017-2022)
  • 10.2.2 Middle East & Africa Gout Therapeutics Market Size by Type (2023-2028)
  • 10.2.3 Middle East & Africa Gout Therapeutics Market Share by Type (2017-2028)
• 10.3 Middle East & Africa Gout Therapeutics Market Size by Application
  • 10.3.1 Middle East & Africa Gout Therapeutics Market Size by Application (2017-2022)
  • 10.3.2 Middle East & Africa Gout Therapeutics Market Size by Application (2023-2028)
  • 10.3.3 Middle East & Africa Gout Therapeutics Market Share by Application (2017-2028)
• 10.4 Middle East & Africa Gout Therapeutics Market Size by Country
  • 10.4.1 Middle East & Africa Gout Therapeutics Market Size by Country (2017-2022)
  • 10.4.2 Middle East & Africa Gout Therapeutics Market Size by Country (2023-2028)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Takeda Pharmaceutical Company
  • 11.1.1 Takeda Pharmaceutical Company Company Details
  • 11.1.2 Takeda Pharmaceutical Company Business Overview
  • 11.1.3 Takeda Pharmaceutical Company Gout Therapeutics Introduction
  • 11.1.4 Takeda Pharmaceutical Company Revenue in Gout Therapeutics Business (2017-2022)
  • 11.1.5 Takeda Pharmaceutical Company Recent Developments
• 11.2 Novartis
  • 11.2.1 Novartis Company Details
  • 11.2.2 Novartis Business Overview
  • 11.2.3 Novartis Gout Therapeutics Introduction
  • 11.2.4 Novartis Revenue in Gout Therapeutics Business (2017-2022)
  • 11.2.5 Novartis Recent Developments
• 11.3 AstraZeneca
  • 11.3.1 AstraZeneca Company Details
  • 11.3.2 AstraZeneca Business Overview
  • 11.3.3 AstraZeneca Gout Therapeutics Introduction
  • 11.3.4 AstraZeneca Revenue in Gout Therapeutics Business (2017-2022)
  • 11.3.5 AstraZeneca Recent Developments
• 11.4 GlaxoSmithKline
  • 11.4.1 GlaxoSmithKline Company Details
  • 11.4.2 GlaxoSmithKline Business Overview
  • 11.4.3 GlaxoSmithKline Gout Therapeutics Introduction
  • 11.4.4 GlaxoSmithKline Revenue in Gout Therapeutics Business (2017-2022)
  • 11.4.5 GlaxoSmithKline Recent Developments
• 11.5 Merck
  • 11.5.1 Merck Company Details
  • 11.5.2 Merck Business Overview
  • 11.5.3 Merck Gout Therapeutics Introduction
  • 11.5.4 Merck Revenue in Gout Therapeutics Business (2017-2022)
  • 11.5.5 Merck Recent Developments
• 11.6 Regeneron Pharmaceuticals
  • 11.6.1 Regeneron Pharmaceuticals Company Details
  • 11.6.2 Regeneron Pharmaceuticals Business Overview
  • 11.6.3 Regeneron Pharmaceuticals Gout Therapeutics Introduction
  • 11.6.4 Regeneron Pharmaceuticals Revenue in Gout Therapeutics Business (2017-2022)
  • 11.6.5 Regeneron Pharmaceuticals Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Author Details
• 13.3 Disclaimer

• Table 1. Global Gout Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
• Table 2. Key Players of NSAIDs
• Table 3. Key Players of Corticosteroids
• Table 4. Key Players of Colchicine
• Table 5. Key Players of Urate-Lowering Agents
• Table 6. Global Gout Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
• Table 7. Global Gout Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
• Table 8. Global Gout Therapeutics Market Size by Region (2017-2022) & (US$ Million)
• Table 9. Global Gout Therapeutics Market Share by Region (2017-2022)
• Table 10. Global Gout Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
• Table 11. Global Gout Therapeutics Market Share by Region (2023-2028)
• Table 12. Gout Therapeutics Market Trends
• Table 13. Gout Therapeutics Market Drivers
• Table 14. Gout Therapeutics Market Challenges
• Table 15. Gout Therapeutics Market Restraints
• Table 16. Global Gout Therapeutics Revenue by Players (2017-2022) & (US$ Million)
• Table 17. Global Gout Therapeutics Revenue Share by Players (2017-2022)
• Table 18. Global Top Gout Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gout Therapeutics as of 2021)
• Table 19. Ranking of Global Top Gout Therapeutics Companies by Revenue (US$ Million) in 2021
• Table 20. Global 5 Largest Players Market Share by Gout Therapeutics Revenue (CR5 and HHI) & (2017-2022)
• Table 21. Key Players Headquarters and Area Served
• Table 22. Key Players Gout Therapeutics Product Solution and Service
• Table 23. Date of Enter into Gout Therapeutics Market
• Table 24. Mergers & Acquisitions, Expansion Plans
• Table 25. Global Gout Therapeutics Market Size by Type (2017-2022) & (US$ Million)
• Table 26. Global Gout Therapeutics Revenue Market Share by Type (2017-2022)
• Table 27. Global Gout Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
• Table 28. Global Gout Therapeutics Revenue Market Share by Type (2023-2028)
• Table 29. Global Gout Therapeutics Market Size by Application (2017-2022) & (US$ Million)
• Table 30. Global Gout Therapeutics Revenue Share by Application (2017-2022)
• Table 31. Global Gout Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
• Table 32. Global Gout Therapeutics Revenue Share by Application (2023-2028)
• Table 33. North America Gout Therapeutics Market Size by Type (2017-2022) & (US$ Million)
• Table 34. North America Gout Therapeutics Market Size by Type (2023-2028) & (US$ Million)
• Table 35. North America Gout Therapeutics Market Size by Application (2017-2022) & (US$ Million)
• Table 36. North America Gout Therapeutics Market Size by Application (2023-2028) & (US$ Million)
• Table 37. North America Gout Therapeutics Market Size by Country (2017-2022) & (US$ Million)
• Table 38. North America Gout Therapeutics Market Size by Country (2023-2028) & (US$ Million)
• Table 39. Europe Gout Therapeutics Market Size by Type (2017-2022) & (US$ Million)
• Table 40. Europe Gout Therapeutics Market Size by Type (2023-2028) & (US$ Million)
• Table 41. Europe Gout Therapeutics Market Size by Application (2017-2022) & (US$ Million)
• Table 42. Europe Gout Therapeutics Market Size by Application (2023-2028) & (US$ Million)
• Table 43. Europe Gout Therapeutics Market Size by Country (2017-2022) & (US$ Million)
• Table 44. Europe Gout Therapeutics Market Size by Country (2023-2028) & (US$ Million)
• Table 45. Asia Pacific Gout Therapeutics Market Size by Type (2017-2022) & (US$ Million)
• Table 46. Asia Pacific Gout Therapeutics Market Size by Type (2023-2028) & (US$ Million)
• Table 47. Asia Pacific Gout Therapeutics Market Size by Application (2017-2022) & (US$ Million)
• Table 48. Asia Pacific Gout Therapeutics Market Size by Application (2023-2028) & (US$ Million)
• Table 49. Asia Pacific Gout Therapeutics Market Size by Region (2017-2022) & (US$ Million)
• Table 50. Asia Pacific Gout Therapeutics Market Size by Region (2023-2028) & (US$ Million)
• Table 51. Latin America Gout Therapeutics Market Size by Type (2017-2022) & (US$ Million)
• Table 52. Latin America Gout Therapeutics Market Size by Type (2023-2028) & (US$ Million)
• Table 53. Latin America Gout Therapeutics Market Size by Application (2017-2022) & (US$ Million)
• Table 54. Latin America Gout Therapeutics Market Size by Application (2023-2028) & (US$ Million)
• Table 55. Latin America Gout Therapeutics Market Size by Country (2017-2022) & (US$ Million)
• Table 56. Latin America Gout Therapeutics Market Size by Country (2023-2028) & (US$ Million)
• Table 57. Middle East and Africa Gout Therapeutics Market Size by Type (2017-2022) & (US$ Million)
• Table 58. Middle East and Africa Gout Therapeutics Market Size by Type (2023-2028) & (US$ Million)
• Table 59. Middle East and Africa Gout Therapeutics Market Size by Application (2017-2022) & (US$ Million)
• Table 60. Middle East and Africa Gout Therapeutics Market Size by Application (2023-2028) & (US$ Million)
• Table 61. Middle East and Africa Gout Therapeutics Market Size by Country (2017-2022) & (US$ Million)
• Table 62. Middle East and Africa Gout Therapeutics Market Size by Country (2023-2028) & (US$ Million)
• Table 63. Takeda Pharmaceutical Company Company Details
• Table 64. Takeda Pharmaceutical Company Business Overview
• Table 65. Takeda Pharmaceutical Company Gout Therapeutics Product
• Table 66. Takeda Pharmaceutical Company Revenue in Gout Therapeutics Business (2017-2022) & (US$ Million)
• Table 67. Takeda Pharmaceutical Company Recent Developments
• Table 68. Novartis Company Details
• Table 69. Novartis Business Overview
• Table 70. Novartis Gout Therapeutics Product
• Table 71. Novartis Revenue in Gout Therapeutics Business (2017-2022) & (US$ Million)
• Table 72. Novartis Recent Developments
• Table 73. AstraZeneca Company Details
• Table 74. AstraZeneca Business Overview
• Table 75. AstraZeneca Gout Therapeutics Product
• Table 76. AstraZeneca Revenue in Gout Therapeutics Business (2017-2022) & (US$ Million)
• Table 77. AstraZeneca Recent Developments
• Table 78. GlaxoSmithKline Company Details
• Table 79. GlaxoSmithKline Business Overview
• Table 80. GlaxoSmithKline Gout Therapeutics Product
• Table 81. GlaxoSmithKline Revenue in Gout Therapeutics Business (2017-2022) & (US$ Million)
• Table 82. GlaxoSmithKline Recent Developments
• Table 83. Merck Company Details
• Table 84. Merck Business Overview
• Table 85. Merck Gout Therapeutics Product
• Table 86. Merck Revenue in Gout Therapeutics Business (2017-2022) & (US$ Million)
• Table 87. Merck Recent Developments
• Table 88. Regeneron Pharmaceuticals Company Details
• Table 89. Regeneron Pharmaceuticals Business Overview
• Table 90. Regeneron Pharmaceuticals Gout Therapeutics Product
• Table 91. Regeneron Pharmaceuticals Revenue in Gout Therapeutics Business (2017-2022) & (US$ Million)
• Table 92. Regeneron Pharmaceuticals Recent Developments
• Table 93. Research Programs/Design for This Report
• Table 94. Key Data Information from Secondary Sources
• Table 95. Key Data Information from Primary Sources

List of Figures

• Figure 1. Global Gout Therapeutics Market Share by Type: 2021 VS 2028
• Figure 2. NSAIDs Features
• Figure 3. Corticosteroids Features
• Figure 4. Colchicine Features
• Figure 5. Urate-Lowering Agents Features
• Figure 6. Global Gout Therapeutics Market Share by Application: 2021 VS 2028
• Figure 7. Acute Gout Case Studies
• Figure 8. Chronic Gout Case Studies
• Figure 9. Gout Therapeutics Report Years Considered
• Figure 10. Global Gout Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
• Figure 11. Global Gout Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
• Figure 12. Global Gout Therapeutics Market Share by Region: 2021 VS 2028
• Figure 13. Global Gout Therapeutics Market Share by Players in 2021
• Figure 14. Global Top Gout Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gout Therapeutics as of 2021)
• Figure 15. The Top 10 and 5 Players Market Share by Gout Therapeutics Revenue in 2021
• Figure 16. North America Gout Therapeutics Market Size YoY (2017-2028) & (US$ Million)
• Figure 17. North America Gout Therapeutics Market Size Market Share by Type (2017-2028)
• Figure 18. North America Gout Therapeutics Market Size Market Share by Application (2017-2028)
• Figure 19. North America Gout Therapeutics Market Size Share by Country (2017-2028)
• Figure 20. United States Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 21. Canada Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 22. Europe Gout Therapeutics Market Size YoY (2017-2028) & (US$ Million)
• Figure 23. Europe Gout Therapeutics Market Size Market Share by Type (2017-2028)
• Figure 24. Europe Gout Therapeutics Market Size Market Share by Application (2017-2028)
• Figure 25. Europe Gout Therapeutics Market Size Share by Country (2017-2028)
• Figure 26. Germany Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 27. France Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 28. U.K. Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 29. Italy Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 30. Russia Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 31. Nordic Countries Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 32. Asia-Pacific Gout Therapeutics Market Size YoY (2017-2028) & (US$ Million)
• Figure 33. Asia Pacific Gout Therapeutics Market Size Market Share by Type (2017-2028)
• Figure 34. Asia Pacific Gout Therapeutics Market Size Market Share by Application (2017-2028)
• Figure 35. Asia Pacific Gout Therapeutics Market Size Share by Region (2017-2028)
• Figure 36. China Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 37. Japan Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 38. South Korea Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 39. Southeast Asia Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 40. India Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 41. Australia Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

• Figure 42. Latin America Gout Therapeutics Market Size YoY (2017-2028) & (US$ Million)
• Figure 43. Latin America Gout Therapeutics Market Size Market Share by Type (2017-2028)
• Figure 44. Latin America Gout Therapeutics Market Size Market Share by Application (2017-2028)
• Figure 45. Latin America Gout Therapeutics Market Size Share by Country (2017-2028)
• Figure 46. Mexico Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 47. Brazil Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 48. Middle East & Africa Gout Therapeutics Market Size YoY (2017-2028) & (US$ Million)
• Figure 49. Middle East and Africa Gout Therapeutics Market Size Market Share by Type (2017-2028)
• Figure 50. Middle East and Africa Gout Therapeutics Market Size Market Share by Application (2017-2028)
• Figure 51. Middle East and Africa Gout Therapeutics Market Size Share by Country (2017-2028)
• Figure 52. Turkey Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 53. Saudi Arabia Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 54. UAE Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 55. Takeda Pharmaceutical Company Revenue Growth Rate in Gout Therapeutics Business (2017-2022)
• Figure 56. Novartis Revenue Growth Rate in Gout Therapeutics Business (2017-2022)
• Figure 57. AstraZeneca Revenue Growth Rate in Gout Therapeutics Business (2017-2022)
• Figure 58. GlaxoSmithKline Revenue Growth Rate in Gout Therapeutics Business (2017-2022)
• Figure 59. Merck Revenue Growth Rate in Gout Therapeutics Business (2017-2022)
• Figure 60. Regeneron Pharmaceuticals Revenue Growth Rate in Gout Therapeutics Business (2017-2022)
• Figure 61. Bottom-up and Top-down Approaches for This Report
• Figure 62. Data Triangulation
• Figure 63. Key Executives Interviewed